HONG KONG--(BUSINESS WIRE)--Jun 14, 2025-- Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”) with ownership of approximately 8% of the Company’s outstanding shares, today issued the following letter in response to the Company’s recent false and misleading claims relating to the upcoming Special Meeting of Shareholders (the “Special Meeting”) scheduled for July 8, 2025. The full text of the letter is below and available at www.SaveSinovac.com. Dear fellow Sinovac shareholders, Prime Success, L.P. (together with its affiliates, “Prime Success” or “we”), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), continues to be disappointed by the current Board’s (“1Globe Activist Board”) distortion of the facts about what is at stake at the upcoming Special Meeting of Shareholders (the “Special Meeting”) scheduled for July 8, 2025.